Arcadia Biosciences
RKDA
13 hedge funds and large institutions have $465K invested in Arcadia Biosciences in 2024 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 3 closing their positions.
212% more capital invested
Capital invested by funds: $149K → $465K (+$316K)
1.77% more ownership
Funds ownership: 3.96% → 5.73% (+1.8%)
0% more funds holding
Funds holding: 13 → 13 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$56.4K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$50.6K |
| 3 |
AWM
Atticus Wealth Management
Palm Beach Gardens,
Florida
|
+$1.12K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4.82K |
| 2 |
US Bancorp
Minneapolis,
Minnesota
|
-$14 |
| 3 |
OLVIG
Oliver Lagore Vanvalin Investment Group
Flint,
Michigan
|
-$11 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Mariner
Overland Park,
Kansas
| $148K | – | – | – |
|
2
Vanguard Group
Malvern,
Pennsylvania
| $83.1K | – | – | – |
|
|
3
UBS Group
Zurich,
Switzerland
| $82.6K | +$56.4K | +13,706 | +5,735% |
|
|
4
Geode Capital Management
Boston,
Massachusetts
| $72.8K | +$50.6K | +12,297 | New |
|
5
State Street
Boston,
Massachusetts
| $71.9K | – | – | – |
|
6
Morgan Stanley
New York
| $3.59K | – | – | – |
|
|
AWM
7
Atticus Wealth Management
Palm Beach Gardens,
Florida
| $1.61K | +$1.12K | +272 | New |
|
|
SS
8
SBI Securities
Tokyo,
Japan
| $710 | +$494 | +120 | New |
|
9
Osaic Holdings
Scottsdale,
Arizona
| $444 | – | – | – |
|
10
Group One Trading
Chicago,
Illinois
| $107 | – | – | – |
|
11
Bank of America
Charlotte,
North Carolina
| $65 | – | – | – |
|
12
AssetMark Inc
Concord,
California
| $30 | – | – | – |
|
|
HI
13
Harbour Investments
Madison,
Wisconsin
| $6 | – | – | – |
|
|
TRCT
14
Tower Research Capital (TRC)
New York
| – | -$4.82K | -1,764 | Closed |
|
|
15
US Bancorp
Minneapolis,
Minnesota
| – | -$14 | -5 | Closed |
|
|
OLVIG
16
Oliver Lagore Vanvalin Investment Group
Flint,
Michigan
| – | -$11 | -4 | Closed |
|
RKDA Hedge Fund Activity: Q4 2024 in Review
13 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Arcadia Biosciences (RKDA) for Q4 2024, worth a combined $465K — up 212% from $149K a quarter earlier.
Fund positioning in RKDA was balanced in Q4 2024: 3 funds opened new positions, 3 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, adding an estimated $56.4K. The largest seller was Tower Research Capital (TRC), exiting entirely with an estimated $4.82K sold.
- 13 institutional investors held Arcadia Biosciences (RKDA) as of Q4 2024, unchanged from Q3 2024.
- Funds reported $465K of Arcadia Biosciences stock for Q4 2024, up 212% quarter-over-quarter.
- 3 funds opened new Arcadia Biosciences positions in Q4 2024 and 3 closed out, a net change of 0 holders.
- The largest Arcadia Biosciences buyer in Q4 2024 was UBS Group, an estimated $56.4K added.
- The largest Arcadia Biosciences seller in Q4 2024 was Tower Research Capital (TRC), an estimated $4.82K sold.
Based on aggregated 13F filings for Q4 2024.